Kevin Mcelwee, Chief Scientific Officer at RepliCel Life Sciences, holds 3.66M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Kevin Mcelwee Bought $670,833 shares of RepliCel Life Sciences on Jan 19, 2023 for an estimated value of 60.37K.
What is the percentage of profitable transactions made by Kevin Mcelwee?
The percentage of profitable transactions made by Kevin Mcelwee is 25%.
What is the average return per transaction made by Kevin Mcelwee?
The average return per transaction made by Kevin Mcelwee is -18.60%.
What stocks does Kevin Mcelwee hold?
Kevin Mcelwee holds: REPCF stocks.
What was Kevin Mcelwee’s latest transaction?
Kevin Mcelwee latest transaction was an Informative Buy of $60.37K.
What was Kevin Mcelwee's most profitable transaction?
Kevin Mcelwee’s most profitable transaction was an Informative Buy of REPCF stock on August 21, 2020. The return on the trade was 60.70%.
What is Kevin Mcelwee's role in RepliCel Life Sciences?
Kevin Mcelwee's role in RepliCel Life Sciences is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.